Market cap
$6.426 B
$22.74 +13.70%
Close of 7 Aug 2026
Revenue
$812.0M
#1648 by revenue
Earnings
-$68.1M
Loss-making
Shares outstanding
282,595,186
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Medical Specialities — ranked by market cap
All 44 →Where these numbers come from
Share counts and financials for Caris Life Sciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.